DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Small Molecule Drugs cited in FEDERAL TRADE COMMISSION v. ENDO PHARMACEUTICALS INC.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2016-10-20||119||Endo added three patents relating to an extended-release mechanism: Nos. 7,276,250; 5,662,933; and 5,… (Id. ¶¶ 45-46.) The ’250 patent expires in 2023; the ’933 and ’456 patents expired in 2013. (Id.) …generic Lidoderm did not infringe Patent No. 5,827,529, a Teikoku patent (licensed to Endo) covering certain…acquired patents—Nos. 5,741,510; 6,096,333; and 6,096,334—only one of which (the ’510 patent) was in … drugs, different markets, different patents, different patent litigations, different agreements, different||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|